ClassifieR 2.0: expanding interactive gene expression-based stratification to prostate and high-grade serous ovarian cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
ClassifieR 2.0: expanding interactive gene expression-based stratification to prostate and high-grade serous ovarian cancer ; volume:25 ; number:1 ; day:21 ; month:11 ; year:2024 ; pages:1-13 ; date:12.2024
BMC bioinformatics ; 25, Heft 1 (21.11.2024), 1-13, 12.2024
- Creator
-
McCabe, Aideen
Quinn, Gerard P.
Jain, Suneil
Ó Dálaigh, Micheál
Dean, Kellie
Murphy, Ross G.
McDade, Simon S.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12859-024-05981-6
- URN
-
urn:nbn:de:101:1-2502072116065.885672725298
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:39 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- McCabe, Aideen
- Quinn, Gerard P.
- Jain, Suneil
- Ó Dálaigh, Micheál
- Dean, Kellie
- Murphy, Ross G.
- McDade, Simon S.
- SpringerLink (Online service)
Other Objects (12)
The molecular prognostic score, a classifier for risk stratification of high-grade serous ovarian cancer
Multimodal data integration using machine learning improves risk stratification of high-grade serous ovarian cancer
Histopathologic image–based deep learning classifier for predicting platinum-based treatment responses in high-grade serous ovarian cancer
High-grade serous ovarian cancer: the clone wars
High-grade serous carcinoma with discordant p53 signature: report of a case with new insight regarding high-grade serous carcinogenesis
Combined image and genomic analysis of high-grade serous ovarian cancer reveals PTEN loss as a common driver event and prognostic classifier
First-Line Management of Advanced High-Grade Serous Ovarian Cancer
PARP inhibitors in platinum-sensitive high-grade serous ovarian cancer
Principles of dormancy evident in high-grade serous ovarian cancer
Tumor Evolution and Heterogeneity in High-Grade Serous Ovarian Cancer
MRI for differentiating ovarian endometrioid adenocarcinoma from high-grade serous adenocarcinoma
No evidence for PALB2 methylation in high-grade serous ovarian cancer
The molecular prognostic score, a classifier for risk stratification of high-grade serous ovarian cancer
Multimodal data integration using machine learning improves risk stratification of high-grade serous ovarian cancer
Histopathologic image–based deep learning classifier for predicting platinum-based treatment responses in high-grade serous ovarian cancer
High-grade serous ovarian cancer: the clone wars
High-grade serous carcinoma with discordant p53 signature: report of a case with new insight regarding high-grade serous carcinogenesis
Combined image and genomic analysis of high-grade serous ovarian cancer reveals PTEN loss as a common driver event and prognostic classifier
First-Line Management of Advanced High-Grade Serous Ovarian Cancer
PARP inhibitors in platinum-sensitive high-grade serous ovarian cancer
Principles of dormancy evident in high-grade serous ovarian cancer
Tumor Evolution and Heterogeneity in High-Grade Serous Ovarian Cancer
MRI for differentiating ovarian endometrioid adenocarcinoma from high-grade serous adenocarcinoma
No evidence for PALB2 methylation in high-grade serous ovarian cancer
The molecular prognostic score, a classifier for risk stratification of high-grade serous ovarian cancer
Multimodal data integration using machine learning improves risk stratification of high-grade serous ovarian cancer
Histopathologic image–based deep learning classifier for predicting platinum-based treatment responses in high-grade serous ovarian cancer
High-grade serous ovarian cancer: the clone wars
High-grade serous carcinoma with discordant p53 signature: report of a case with new insight regarding high-grade serous carcinogenesis
Combined image and genomic analysis of high-grade serous ovarian cancer reveals PTEN loss as a common driver event and prognostic classifier
First-Line Management of Advanced High-Grade Serous Ovarian Cancer
PARP inhibitors in platinum-sensitive high-grade serous ovarian cancer
Principles of dormancy evident in high-grade serous ovarian cancer
Tumor Evolution and Heterogeneity in High-Grade Serous Ovarian Cancer
MRI for differentiating ovarian endometrioid adenocarcinoma from high-grade serous adenocarcinoma